1999
DOI: 10.1212/wnl.53.4.894
|View full text |Cite
|
Sign up to set email alerts
|

Pulse cyclophosphamide therapy in CIDP

Abstract: To the Editor: The Quality Standards Subcommittee of the American Academy of Neurology has endorsed guidelines for management of concussion in sports. 1 This practice parameter represented a consolidation and modification of previous concussion guidelines in sports. 2,3 A major limitation and criticism of most management guidelines for concussion in sports has been that the determination of criteria for return to play has been arbitrarily established, based on theoretical considerations and limited clinical in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2000
2000
2022
2022

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 1 publication
0
1
0
Order By: Relevance
“…31 Others have reported the successful treatment of some patients with cyclosporin A 32-34 or cyclophosphamide. 35,36 In the renal transplant field the purine synthesis inhibitor, mycophenolate mofetil, is supplanting azathioprine and would be worth testing in CIDP. 37 Determining which agents offer real benefit will require large multicentre trials because CIDP is heterogeneous, variable in outcome and uncommon.…”
Section: Chronic Inflammatory Demyelinating Polyradiculoneuropathymentioning
confidence: 99%
“…31 Others have reported the successful treatment of some patients with cyclosporin A 32-34 or cyclophosphamide. 35,36 In the renal transplant field the purine synthesis inhibitor, mycophenolate mofetil, is supplanting azathioprine and would be worth testing in CIDP. 37 Determining which agents offer real benefit will require large multicentre trials because CIDP is heterogeneous, variable in outcome and uncommon.…”
Section: Chronic Inflammatory Demyelinating Polyradiculoneuropathymentioning
confidence: 99%